World Laboratory Day: Laboratory medicine in transition
Menu

Image: Illustration of a pulmonary embolism, a potentially fatal complication caused by a venous thrombosis.

Portable diagnostic device for early detection of deep vein thrombosis

19.06.2024

A new EU-funded project called ThrombUS+ aims to detect vein thrombosis at an early stage. Vein thrombosis poses a significant health risk, often occurring without symptoms and potentially leading to life-threatening pulmonary embolisms. The project is developing a portable solution that enables continuous monitoring and immediate detection.
Read more
Image: A man looks through a microscope in the foreground, while a woman stands in the background and explains something to him; Copyright: Messe Düsseldorf/Andreas Wiese

Messe Düsseldorf/Andreas Wiese

World Laboratory Day: Laboratory medicine in transition

16.04.2024

World Laboratory Day takes place annually on April 23. It is intended to draw attention to the work in laboratories and the achievements of laboratory employees. MEDICA-tradefair.com takes the day as an opportunity to highlight current trends that continue to shape these work environments. These trends will also be a main focus of the MEDICA LABMED FORUM at MEDICA 2024.
Read more
Image: A woman lies on her back covered with a hairnet and is examined with a measuring device on her facial skin.

Raman sensor system: non-invasive monitoring with wide-ranging applications

04.04.2024

The Raman sensor system opens new monitoring possibilities by precisely measuring the concentration of carotenoids in the skin - a potential indicator of health. This technology offers a non-invasive insight into dietary habits and health status, with the potential to monitor the effectiveness of chemotherapies.
Read more
Image: The SARS-CoV-2 pandemic has shown the need for preparedness for possible future pandemics.

EU-Funded Project PAIR improves pandemic preparedness

08.02.2024

The EU-funded project PAIR has just started in Copenhagen with the participation of 20 partners from seven countries. This five-year project aims to ensure that Europe possesses the expertise and capabilities for advanced point-of-care systems and prognostic models based on artificial intelligence and machine learning.
Read more
Inage: Sitting pregnant woman holding her belly with both hands; Copyright: djoronimo

djoronimo

Pre-eclampsia diagnosis in focus: MOMM Diagnostics' rapid test

22.12.2023

Early diagnosis is crucial in the case of pregnancy toxemia or pre-eclampsia. The young company MOMM Diagnostics is developing a diagnostic tool to help detect pre-eclampsia quickly and accurately. The start-up was already able to present an initial prototype of préXclude at MEDICA 2023. Clinical trials are due to start soon.
Read more
A man in a suit walks through the MEDICA exhibition hall with a microphone; copyright: beta-web | Messe Düsseldorf

eHealth, mHealth, AI, and much more – Highlight tour in the MEDICA START-UP PARK

13.11.2023

Every year, the MEDICA START-UP PARK attracts a lot of visitors. Young, up-and-coming companies present their products here – often for the first time ever. This stand has already been the starting point for the success stories of some companies that are now internationally active. At MEDICA 2023, we are once again taking the opportunity to talk to promising start-ups.
Read more
Image: Rebecca Richards-Kortum smiles at the camera in a lab; Copyright: Brandon Martin/Rice University

Brandon Martin/Rice University

Affordable global health technologies for early cancer detection

06.11.2023

A Rice University-led collaboration from three continents has won up to a five-year grant from the National Institutes of Health to establish a premier research center in the Texas Medical Center to develop affordable, effective point-of-care (POC) technologies that improve early cancer detection in low-resource settings in the United States and other countries.
Read more
Image: A woman hands a yellow piece of paper to a man across a table where another person is also sitting; Copyright: InfectoGnostics

InfectoGnostics

InfectoGnostics study: Benefits of on-site tests in general practices

05.09.2023

General practitioners (GP) regularly use on-site rapid tests because they find their application useful. However, frequent utilisation fails due to costs and remuneration regulations. These are the results of a study by InfectoGnostics researchers at the University Hospital Jena in the project "POCT-ambulant", in which 292 GPs in Thuringia, Bremen and Bavaria participated.
Read more
Image: Child being tested for viruses in the throat by a doctor using a test swab; Copyright: drazenphoto

drazenphoto

Revolutionizing virus detection: the power of AI and CRISPR

04.07.2023

In the midst of the COVID-19 pandemic, scientists and researchers have been tirelessly working to develop innovative and accurate tests to identify the presence of viruses. One breakthrough technology that has emerged is the combination of artificial intelligence (AI) and CRISPR, which has revolutionized virus detection.
Read more
Image: Close up of test tubes in a laboratory; Copyright: leungchopan

leungchopan

AI helps create better, simpler hepatitis, COVID-19 tests

11.05.2023

University of Florida scientists have used artificial intelligence tools to simplify a test that works for both hepatitis C and SARS-CoV-2, the virus that causes COVID-19. The simplified test happens in one small test tube in just a few minutes.
Read more
Image: Picture of the complete sensor with a PDMS well of 100 μl volume for the drop test; Copyright: HZDR/Sandoval Bojorquez

HZDR/Sandoval Bojorquez

Nanobiosensor developed for detecting SARS-CoV-2

04.04.2023

Infection and immunity status of the population are considered key parameters for handling pandemics. For this purpose, detecting antigens and antibodies is of great importance. The devices currently used for this purpose - what are known as point-of-care (POC) devices- are one option for rapid screening. Their sensitivity, however, needs further improvement.
Read more